Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

BackgroundAddition of gemcitabine and cisplatin (GP) or docetaxel and cisplatin plus fluorouracil (TPF) to concurrent chemoradiotherapy (CCRT) significantly improved survival in locoregionally advanced nasopharyngeal carcinoma (NPC). However, an economic evaluation of these regimens remains unknown....

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Jiangping Yang, Jiaqi Han, Jinlan He, Baofeng Duan, Qiheng Gou, Ping Ai, Lei Liu, Yanchu Li, Kexing Ren, Feng Wang, Min Yao, Nianyong Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Subjects:	cost-effectiveness nasopharyngeal carcinoma induction chemotherapy gemcitabine docetaxel cisplatin
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.594756/full